Deutsche Lufthansa AG

XETRA:LHA

Good morning, and welcome to the ADM Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I'd now like to introduce your host for today's call, Megan Britt, Vice President, Investor Relations for ADM. Ms. Britt, you may begin.

Welcome to the fourth quarter earnings conference call for ADM. Our prepared remarks today will be led by Juan Luciano, Chair of the Board and Chief Executive Officer; and Monish Patolawala, our EVP and Chief Financial Officer. We have prepared presentation slides to supplement our remarks on the call today, which are posted on the Investor Relations section of the AM website and through the link to our webcast.

Some of our comments and materials may constitute forward-looking statements that reflect management's current views and estimates of future economic circumstances, industry conditions, company performance and financial results. These statements and materials are based on many assumptions and factors that are subject to numerous risks and uncertainties.

ADM has provided additional information in its reports on file with the SEC concerning assumptions and factors that could cause actual results to differ materially from those in this presentation and the materials. Unless otherwise required by law, ADM assumes no obligation to update any forward-looking statements due to new information or future events.

In addition, during today's call, we'll refer to certain non-GAAP or adjusted financial measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are available on our earnings press release and presentation slides, which can be found in the Investor Relations section of the ADM website.

I'll now turn the call over to Juan.

Thank you, Megan. Hello, and welcome to all who have joined the call. Please turn to Slide 4, where we have captured our fourth quarter and full year performance highlights. Today, ADM reported fourth quarter adjusted earnings per share of $1.14 and full year adjusted earnings per share of $4.74, a in line with the midpoint of our guidance for the full year.

Total segment operating profit was $1.1 billion for the fourth quarter and $4.2 billion for the full year. Our trailing fourth quarter adjusted ROIC was 8.3%, and cash flow from operations before working capital changes was $3.3 billion. Though 2024 presented a variety of challenges, our diligent focus on improving operations has netted positive impact across the network.

We achieved strong crush volumes in canola and rapeseed as well as in our LatAm region. We've made progress on addressing challenges in North American soy assets, reducing unplanned downtime and improving crush volumes in the month of December. We successfully ramped up run rates to meet demand at our Spirit Wood facility over the course of 2024.

We achieved a strong year in starches and sweeteners were improved planned performance led to 3% higher production volume year-over-year, helping several product lines in our North America business set operating profit records. We made progress in addressing demand fulfillment challenges in EMEA flavors, while successfully integrating 2 new flavors acquisitions announced in early 2024.

We've improved our safety record significantly with more than 35% year-over-year reduction in Tier 1 and 2 process safety incidents across our global network. In addition, we advanced key innovation initiatives in areas such as biosolutions and Health & Wellness, continuing to support growing customer demand in these parts of the business.

And through this, we were able to maintain a strong balance sheet to ensure continued investment in the business and return of cash to shareholders. And earlier today, we announced an increase in our quarterly dividend making our 93rd consecutive year of uninterrupted dividends. As we wrap up 2024, we are encouraged that we're gaining operational momentum and we see opportunities to drive additional value. But we also recognize that the external environment continues to post uncertainties and challenges.

Please turn to Slide 5. We've entered 2025 knowing that we need to remain agile to manage through shifts in both trade and regulatory policy around the world, along with the related impacts on geographic supply and demand. With a global asset base and constantly evolving product innovation, our team is prepared to pivot as needed to support the resiliency of the ag, food energy and industrial sectors we serve.

We're taking these factors into account as we define our business priorities for 2025 with an emphasis on continuing to improve in the areas we control. First, we are focused on execution and cost management. Having made progress on the issues that impacted North American soy operations, we are applying that experience to the broader global network to drive further operational improvement and cost reductions.

Similarly, we're applying what we learn from addressing demand fulfillment challenges in EMEA flavors to drive improvements in similarly challenged areas such as pet nutrition. We're actively managing our sourcing efforts to take advantage of lower pricing in many of our core input costs such as chemicals and energy. This cost agenda has also supported realigning our focus on data analytics to identify and assess new savings opportunities quickly.

We're aggressively managing our SG&A and corporate cost as we make shifts in the business portfolio and lean into our strengthening digital capabilities. We have been diligent in finding ways to prioritize our own organizations work, which has highlighted opportunities to eliminate noncritical third-party spend and structurally align our organization against our most critical efforts.

As part of this prioritization effort, we announced that we're taking targeted actions across both business and corporate functions to reduce approximately 600 to 700 roles, including approximately 150 unfilled positions. Decisions impacting our team members are never easy to make. And we are ensuring these colleagues are receiving transition support and an opportunity to apply for other critical roles within the company.

In total, we anticipate the result of these cost actions to deliver in the range of $500 million to $750 million over the next 3 to 5 years with $200 million to $300 million in 2025. In conjunction with improving our cost position, our second focus is on strategic simplification. As a company that has grown substantially over the past decade, we are continually evaluating how our portfolio balances the evolving needs of our customers, our expectations to achieve our returns objectives and our ability to be the most efficient operators of each part of the business both the current external environment and our performance in specific business segments and geographies over the past few years have highlighted additional opportunities to strategically assess how we are focusing our operational capabilities.

With this, we are considering a phased approach to areas of potential simplification, looking at our business through a variety of lenses with a particular focus on places where we see a history of performance challenges deteriorating demand and or excess capacity that do not have a clear path to improvement.

Assets that may require capital investment that does not meet our expected returns objectives, opportunities for targeted synergy acceleration including potential closures and divestitures, where we see an overlap in capabilities and asset footprint, determining who is the best owner/operator for asset that may not be assessed as critical to ADM's future growth trajectory. And along with this, we are ensuring our organization, both our colleagues and the strategic partners are aligned and focus on the most critical sources of Vale.

We have currently identified a pipeline of approximately $2 billion in portfolio opportunities and we will execute on this over time with the objective of maximizing value for ADM shareholders. Please turn to Slide 6, where we'll talk about 2 more areas of focus in 2025 associated with capital management. First, as we look at the strategic growth opportunities, we will continue to invest in value drivers.

Our strategy continues to be based on the balance of both productivity and innovation and growth-oriented organic investment remains part of that equation. We've highlighted areas where investments have been paying off over the past year from our modernization and digitization efforts across our facilities, to the ramp-up of additional capacities such as Spiritwood to support renewable diesel demand to the global partnerships we have announced in [ Regenag ] supporting farmers' resiliency.

All of these represent targeted areas where our business segments are evolving with our customers and finding ways to deliver a strong return on our investments. Looking now to 2025 and beyond, we will continue to make targeted investments in part of the portfolio where we can drive further growth and differentiation whether that's continuing plant digitization and upgrading our equipment to enhance operating leverage, expanding destination marketing volumes in targeted markets, continuing to build out our decarbonization solution portfolio or supporting the continued evolution of the biofuels and energy sector.

Investments in areas such as biosolutions, destination marketing and biotics has helped us to drive double-digit growth and serves as a model for new investments. The portfolio above represents proven winners that are not only organically improving ADM, but also helping us establish foundations for the next wave of growth.

We will also continue to return cash to shareholders through our traditional channels. In 2024, we kept our focus on returning capital to shareholders through repurchases and dividends all while maintaining our leverage ratio at our desired target. We've extended our existing share repurchase program by 100 million shares which we will approach opportunistically and to address dilution.

We've announced another dividend increase, continuing the cycle of annual increases for over 50 consecutive years. And through this, we expect to maintain a leverage ratio of approximately 2.0x. To summarize, looking across the focus areas for 2025, we are committed to continuing to improve in the areas we control, and we feel confident that this will allow ADM to deal with external uncertainties and challenges while positioning the company for long-term success.

Our team has managed our business through multiple challenging windows of time over nearly 125 years, and I fully expect us to rise to the occasion again in 2025. With that, I will hand it over to Monish to share a deeper dive on 2024 financial results and our 2025 outlook.

Thank you, Juan. Please turn to Slide 7. Before jumping into segment performance, let me quickly recap some of the financial highlights for the fourth quarter and full year 2024. While the fourth quarter played out largely as expected, we experienced negative pressure from market conditions later in December. For the full year, we finished within our previously guided adjusted earnings per share range.

The team remains focused on key self-help actions to finish the year and enter into 2025 on a stronger footing. Now transitioning into highlights on segment performance, and starting with AS&O. To start, let me provide some perspective on the broader market environment and the dynamics that shape the fourth quarter. The operating landscape was challenging in the fourth quarter with biofuel and trade policy uncertainty at the forefront.

Ample global supplies, higher crush rates from Argentina and uncertainty in biofuel and trade policy negatively impacted the crush environment. We also experienced high manufacturing costs. As a result, soybean and canola crush execution margins were approximately $10 per ton and $20 per tonne lower, respectively, versus the prior year period. Also included in the fourth quarter results for our crushing subsegment were $52 million of insurance proceeds related to the partial settlement of the Decatur East and Decatur West insurance claims.

Increased pretreatment capacity at renewable diesel facilities as well as the continued elevated import levels of used cooking oil also weighed on both biodiesel and refining margins during the quarter. From a food oil perspective, we continue to experience softer demand from customers as they look to cut costs. The origination environment was supportive in North America, as the logistical challenges related to the U.S. river levels eased compared to the prior year.

Overall, against this backdrop, AS&O segment operating profit for the fourth quarter was $644 million, down 32% compared to the prior year period. For the full year, AS&O segment operating profit of $2.4 billion was 40% lower versus the prior year. Looking at subsegment performance for the full year, Ag Services subsegment operating profit of $715 million was 39% lower versus the prior year, driven primarily by lower South American origination volumes and margins in part due to industry take-or-pay contracts.

The stabilization of trade flows also led to fewer opportunities in our global trade business. Crushing subsegment operating profit of $844 million was 35% lower versus the prior year as ample global supplies drove more balanced supply and demand conditions which negatively impacted margins throughout the year.

Executed crush margins were approximately $10 per ton lower versus the prior year in soybean and approximately $15 per ton lower in canola versus the prior year. There were net negative timing impact of approximately $165 million year-over-year. The full year also included $76 million of insurance proceeds for the partial settlement of the Decatur East and Decatur West claims related to the incident in 2023.

Refined products and other subsegment operating profit of $552 million was 58% lower compared to the prior year as increased pretreatment capacity at renewable diesel facilities higher imports of used cooking oil, aggressive competition among food all suppliers to serve customer demand and biofuel policy uncertainty negatively impacted margins. There were net negative timing impact of approximately $430 million year-over-year.

Equity earnings from the company's investment in [ Wilmar ] was $336 million for the full year, 11% higher compared to the prior year. Turning to Slide 8. Carbohydrate Solutions unfolded as expected in the fourth quarter as operating profit was largely in line with the prior year. The results reflected robust demand for ethanol.

However, higher industry production drove a lower margin environment. Results also reflected strong North American Starches and Sweeteners performance as well as $37 million of insurance proceeds related to both the partial settlement of the Decatur East and Decatur West insurance claims. For the full year 2024, Carbohydrate Solutions segment operating profit of $1.4 billion was flat compared to the prior year.

Starches and Sweeteners subsegment operating profit of $1.3 billion was slightly higher compared to the prior year as strong volumes and margins in North America were offset by weaker core product values and lower margins in EMEA and ethanol. The full year also included $84 million of insurance proceeds for the partial settlement of the Decatur East and Decatur West claim related to the incident in 2023.

Vantage Corn Processors subsegment operating profit of $33 million was 28% lower compared to the prior year as lower margins due to the higher industry production more than offset robust demand for ethanol exports. Turning to Slide 9. In the fourth quarter, in the Nutrition segment, weaker consumer demand and ongoing headwinds from unplanned downtime at Decatur East drove lower organic revenues.

Operating profit was $88 million in the fourth quarter, higher year-over-year due to improved mix lapping the negative nonrecurring items in the prior year and insurance recoveries of $46 million related to the partial settlement of the Decatur East insurance claim. The quarter also included a negative impact due to higher cost of goods sold associated with the termination of an unfavorable supply agreement.

Full year nutrition revenues were $7.3 billion, up 2% compared to the prior year. On an organic basis, revenue was down 3%. Human Nutrition revenue was roughly flat organically as headwinds related to the unplanned downtime indicator East and [indiscernible] pricing offset improved mix and volumes in flavors and health and well. Animal Nutrition revenue declined due to unfavorable mix, negative currency impact in Brazil and lower volumes due to demand fulfillment challenges.

Full year nutrition segment operating profit of $386 million was 10% lower versus the prior year. Human Nutrition subsegment operating profit of $327 million was 22% lower compared to the prior year, primarily driven by unplanned downtime at Decatur East and higher manufacturing costs, partially offset by improved performance in the Health & Wellness business favorable mix in the flavors business and M&A contribution.

The Human Nutrition subsegment full year results also included $71 million of insurance proceeds for the partial settlement of the Decatur East claim related to an incident in 2023. Animal Nutrition subsegment operating profit of $59 million was higher than the prior year due to higher margins supported by cost optimization actions to improve mix and an increase in volumes.

Please turn to Slide 10. In 2024, the company generated cash flow from operations before working capital of approximately $3.3 billion, down 30% relative to the prior year due to lower total segment operating profit. Despite the decline, solid cash generation supported our ability to invest in our business and return excess cash to shareholders.

In 2024, the company returned $3.3 billion in the form of dividends and share repurchases, allocated $1.6 billion to capital expenditures to support the reliability of our assets and cost efficiencies and approximately $1 billion to M&A announced in 2023 and completed in January 2024. Our strong capital structure remains a critical differentiator for the company.

We will continue to seek opportunities to further strengthen our balance sheet to provide us financial flexibility to organically invest in the business to enhance returns and create long-term value. As Juan mentioned, targeted portfolio simplification actions, including consolidation and divestitures will help align our focus on value creation.

At the same time, we remain committed to returning cash to shareholders and will look to offset dilution and opportunistically seek share repurchases. We recently announced an increase in our quarterly dividend as well as an extension of our share repurchase program, which is up to an additional 100 million shares over the next 5-year period.

Please turn to Slide 11. We have already touched on some of the external market dynamics that we navigated in December and several of these dynamics are expected to persist and create pressure on our first half results for 2025 and particularly for our AS&O segment. These include market headwinds related to U.S. biofuel policy uncertainty that have negatively impacted U.S. vegetable oil demand and biodiesel margins, higher global soybean stock levels and an increase in Argentinian crush rates, which have pressured global soybean meal values and trade policy uncertainty with Canada and China, which has driven volatility for canola crush margins.

Taken together, these factors are driving significantly lower meal and vegetable oil values, which is reflected by replacement crush margins in North America, near $40 per metric ton for soybean and $50 per metric ton for canola. In both cases, these are well below the levels that we experienced in the first half of last year.

As we look to the second half of 2025, we see signs that make us optimistic about margin improvement over the course of the year. One clear indication is board crush value signaling or carrying the market in the second half. Additionally, as we progress through the year, we expect policy uncertainty to clear and strong fundamentals to support better crush and biodiesel margin. In particular, we expect clarity on 45 guidance to support strong U.S. demand for crop-based vegetable oil. We also expect expansion of global biofuels policy to support global vegetable oil demand.

Key examples include Brazil with increases in bar diesel mandates and the newly implemented SaaS mandates in Europe. Lastly, we expect improvement in the livestock sector to support robust meal demand. Overall, with the market set up into 2025, we are focused on operational improvements and accelerating cost savings to partially mitigate the less favorable market conditions and be in an excellent position to capture opportunities in the second half.

Turning to Slide 12. We have provided details that support our 2025 outlook for each segment for the first quarter and the full year. Starting with Ag Services and oil sales. In the first quarter, we expect segment operating profit to be down approximately 50% relative to the prior year period, led by declines in crushing and RPO.

On crushing, we anticipate both soybean and canola execution crush margins to be significantly lower than the prior year period. RPO In lower biodiesel margins are expected to drive significantly lower operating profit for the subsegment in the first quarter compared to the prior year period. For the full year, we expect AS&O segment operating profit to be below to similar with 2024. Operational improvements should support higher volumes and lower manufacturing costs, which will partially offset the impact of lower margins for the segment.

For the full year, we expect soybean crush execution margins to range from $45 to $55 per tonne, down approximately $5 per ton at the midpoint versus the prior year. We expect canola crush execution margins to range from $50 to $70 per tonne, down approximately $20 per ton at the midpoint compared to the prior year.

For RPO, we expect operating profit to be down significantly compared to the prior year. We expect insurance recoveries related to the Decatur claim of $25 million compared to the total recoveries of $76 million in 2024. In Carbohydrate Solutions for the first quarter, we expect segment operating profit to be lower by approximately 5% to 15% compared to the prior year period.

Strong margins and volumes in North American starches and sweeteners are likely to be offset by lower results in the EMEA region as higher corn cost and increased competition negatively impact margins. In ethanol, robust export demand is likely to support strong volume. However, higher industry run rates are expected to result in breakeven ethanol EBITDA margin.

For the full year, we expect lower Carbohydrate Solutions segment operating profit relative to the prior year period as strong volumes and margins in North America are expected to be more than offset by margin moderation in EMEA and ethanol. For the year, we anticipate ethanol EBITDA margins to be in the range of $0.05 to $0.10 down approximately $0.10 at the midpoint compared to the prior year.

We expect insurance recovery of approximately $10 million compared to the insurance recovery of $84 million in 2024. In Nutrition, we expect first quarter operating profit to be down 50% compared to the prior year period. We expect to face higher raw material costs and negative impacts associated with continued downtime at Decatur East. We also expect lower demand for plant-based proteins, higher insurance costs and increased competition and [ texturant ] to drive lower margins in this segment.

Notably, excluding the effects of $46 million of insurance proceeds we received in the fourth quarter of 2024, we expect Nutrition operating profit to be approximately flat sequentially in the first quarter. For the full year, we anticipate nutrition operating profit to be higher compared to the prior year with low to mid-single-digit revenue growth led by our Flavors business. Strong performance from recent acquisitions and improved supply chain execution is expected to support increased volumes and an improvement in cost in human nutrition, helping to offset the headwinds associated with the ramp-up of operations at Decatur East.

In Animal Nutrition, we anticipate continued mix benefits from cost optimization actions as well as an improvement in profitability of our pet business. We expect insurance recovery of approximately $25 million compared to insurance recovery of $71 million in 2024. Now looking at the consolidated outlook on Slide 13. Earlier today, we announced that we expect adjusted earnings per share to be between $4 to $4.75 per share.

In considering this range, it is important to keep in mind the following: We expect lower margins in AS&O and [indiscernible] to create a material headwind. Our focus on improved execution and cost should produce $200 million to $300 million of cost out, which includes the benefit of lower manufacturing and SG&A costs. We expect to reverse the negative take-or-pay impact in ag services from last year. We also anticipate less insurance proceeds in 2025.

We currently expect approximately $60 million in 2025 with approximately 60% coming from reinsurance. This is compared to total insurance recoveries of $231 million in 2024 with approximately $133 million coming from reinsurance in 2024.

Looking at our other guidance metrics, we anticipate corporate costs to be within the range of $1.7 billion to $1.8 billion. We expect the benefit of cost actions and a decline in net interest expense in corporate to be more than offset by the elevated legal costs and the reversal of performance-based reductions in incentive compensation relative to 2024.

In other, we expect lower results in ADMIS compared to the prior year due to lower interest rates. We expect capital expenditures to be in the range of $1.5 billion to $1.7 billion, and we expect D&A to be approximately $1.2 billion. We expect our effective tax rate to be higher in 2025 in the range of 21% to 23% due to the sunset of the biodiesel tax credit, a shift in geographic mix of earnings and an expansion in the global minimum tax.

Lastly, we expect diluted weighted average shares outstanding to be approximately 483 million shares and our leverage ratio to be approximately 2% for the full year. To conclude, I want to take a moment to thank our ADM colleagues for their focus adaptability and contributions through the close of 2024. These organizational efforts have been critical in driving progress and meeting challenges head on.

As we navigate 2025, our focus will remain on what is within our control. A full commitment to remediating the material weakness and making strides to strengthen our internal control driving execution to improve operational performance and lower costs, while sustaining functional excellence, unlocking additional capital to drive value and position the company for long-term success.

These efforts position us in our ability to navigate the current dynamic environment and reinforce our confidence in delivering on our commitments. Before I turn it back to Juan I wanted to briefly mention a leadership transition we announced last week and that officially will take effect on March 1. [ Cheri Nichols ] is joining us as our new Vice President and Chief Accounting Officer. She joined us from Cargill where she served as Senior Vice President, Chief Accounting Officer and Global Process Leader. I am excited to make this important addition to our leadership team, and I look forward to working with her.

Back to you, Juan.

Thanks, Monish. I briefly close by recapping our focus as we continue the path into 2025. With the uncertainty we've noticed in the external environment, ADM is prioritizing an internal focus on the areas we can best control. While administering this self-help will remain agile and ready for opportunities that may present themselves along the way.

Our focus on execution and cost management will drive savings to the bottom line while ensuring that we're managing our assets and overall network as effectively as possible. Our focus on strategic simplification will deliver opportunities to optimize our portfolio and organization around those areas that deliver strongest returns and where we are the strongest operators.

Our focus on strategic growth will allow us to organically invest in proven winners while also ensuring our business are ready for the future. And our focus on capital discipline will position us to continue the return of cash to shareholders through dividends and selective share repurchases.

We are confident that this equation sets ADM up for success in 2025 and ensures we have necessary optionality in both the short and medium term while keeping our eyes on longer-term opportunities ahead. With that, we'll take your questions now. Operator, please open the line.

[Operator Instructions] Our first question for today comes from Tom Palmer of Citi.

On the Nutrition segment, I wanted to make sure I understood the expected profit recovery. It implies a pretty big inflection as the year progresses. You noted 1Q has some maybe heightened headwinds. It sounds like at least for the second quarter. I wasn't sure if it was second quarter or for the full year. The start-up at Decatur noted as the headwind and then you've got the insurance headwind, especially in the second half.

So just trying to understand what really drives that inflection? Is it the belief that end markets get better? Is this cost savings plan maybe more concentrated in this part of the business?

Yes. Thank you, Tom, for the question. Listen, Nutrition has a big self-help story inside themselves as we have in AGM, of course, but I think the main issue for Nutrition is you need to think about like 3 different buckets. There is one bucket that is Decatur is plant, which is a specialty ingredients. That is a big headwind. And until we can bring the plant back that will continue to be. So that's what's going to happen in the first quarter. Hopefully, the plant will be back in the second quarter, we expect, and that will naturally bring an improvement to the results.

The other bucket is a bucket that it continues to go very well, which is, if you think about flavors and if you think about biotics, those businesses are going very well. They are growing, they have grown 7% and 10%, respectively, in revenue in 2024, so that's going to continue, and that's basically execution of their pipeline and their pipeline is very robust and very good.

And I will say the third bucket is you have this steady improvement month-over-month, quarter after quarter of animal nutrition, which is not a revenue story, but it's a margin improvement story. You have 3 different things. And when you put them all together, we see a strong recovery in the last half of the year for Nutrition.

Tom, just to add, and I know you already picked it up but just for Matt. When you look at it sequentially, so you're right, Q1 starts softer. Sequentially, after adjusting for the insurance recovery, which we have $46 million, we expect those results to be pretty much in line Q1 equals Q4. And as Juan mentioned, the manufacturing cost, all the self-help starts kicking in. In the second quarter, the fourth quarter.

Our next question comes from Andrew Strelzik of BMO.

I wanted to ask now that we've got the I wanted to ask about your view on vegetables and soybean oil demand in particular. Now that we have the 450 guidance behind us to a certain extent, and the imported you go that's not going to qualify for tax credits. In kind of your first half, back half, summary there slide. You gave what I would say is a reasonably constructive outlook for vessel oil demand.

So I guess I'm just curious for how you think about the puts and the takes around that because I know there's a lot of concern in the market. And then kind of subsequent to that, as you think about all the uncertainty that's impacting the first quarter, is there a way to think about kind of the first half, back half earnings split relative to what is typical for you guys?

Yes. Thank you, Andrew. A lot to unpack there. So yes, we received guidance from 45 in January, and I think it was constructive. But there's still a lot is in the area. We still need to get finalized that guidance probably is not going to happen until the end of Q1.

And by that time, we might have sold already in Q2. So we have to see how that evolves. So we have to be cautious with that. On the other hand, when you do the math, that probably implies an extra maybe 0.5 million tonnes of oil demand by UCO that is not going to qualify for this. Our team anticipates that soybean oil share will be up from 35% to 40% and maybe you go down from 20% to 14%.

So I think that this is a year in which right now, the [indiscernible] and oil industry is trying to digest this extra capacity, if you will, extra production because we have North America, we have Brazil and we have Argentina produced crushing a lot. And also this big uncertainty, not only on tariffs, for imported products, but also the policy uncertainty around biofuels.

We think that as these policy uncertainties start to clear through the year, we're going to see margins improving. And you can see that in the currency in the market for crush going forward. We are excited about the manufacturing improvements we're going to have, and we are excited about the fundamental demand that when these clouds of uncertainty regulatory will clear, you will see that the livestock area is very strong and soybean meal continues to be the most beneficial feeding material.

So that's maximizing the [indiscernible] at the moment. So USDA is thinking mill growth probably 5.5%, maybe we have even some upside to that number potentially. And then you have this area of all the mandates that are coming around the world. I think Monish referred before in his previous remark about SAF in Europe, but also it's in Indonesia, also is Brazil increasing their biofuels mandates.

And when we clear 45, we're going to have that extra demand from the U.S. So we see a first half, second half different pattern than other years and very hard to quantify what else on one or the other because it will depend more on government and clarifying the regulatory environment, which we can only adjust to, but we cannot manage.

Our next question comes from Ben Theurer of Barclays.

Perfect. Just wanted to follow up on your guidance cadence for ex service in Allstate similar to what Tom had on Nutrition. But as we look at it, obviously, Q1 is a very tough comp, and you already indicated that to be 50% down. But then in order to get to just slightly below '25 levels as your guidance indicates, that would mean that 2Q onwards we should see improving trends on a year-over-year basis.

And I just would like to understand if you can help us reconcile that with lower insurance proceeds, but then at the same time, you assume canola and soybean crushed to be lower for the year. So I just wanted to understand what is in there that helps us to get those profits to in line to below versus 24% with such a tough start in 1Q?

Yes. I think then part of the tough start in the Q is because although you see some canola margins maybe rebounded recently when we put our book, we put our book at lower numbers because we put it here in Q4. So maybe our Q1 is even lower than maybe what current conditions may indicate when we think about crush margins approximately around $40 in Q1, we are expecting full year crush margins in the range of $45 to $55 per ton for soy.

That's about $5 lower than the average of last year. And canola $50 to $70, that's probably $20 lower than last year. And again, you have to include here all the improvements that we expected in manufacturing for the business. If you recall, last year, we were doing a lot of project automation and digitization in the car solutions area. And I mentioned before, that we have run an experiment with the Oilseed plant in Brazil. And now we have the result of that experiment, and we are bringing some of those learnings.

So we expect a lot of self-help coming to Ag Services and Oilseeds. And we also expect destination marketing to grow our internal -- our direct farming procurements also to improve or to grow this year. And as I said, mill is going to be strong and soybean oil should become significantly better in the second half of the year.

And Ben, I would add to Juan's comments just when you think about RPO or biofuels and what clarity that gets, that should allow the second half to be far stronger than the first half. And Juan already mentioned, when you look at the forward curve that carry is pretty strong in the second half, and we are open for business quite a lot in the second half. So hopefully, we are positioned to take advantage to capture as that goes.

So all that put together, why you start pretty soft in Q1 and then you move yourself up. But you're right, it's a second half story and that's what we'll have to watch. Multiple factors is you are watching. We are watching the same, whether it's weather, whether it is the crop yields, et cetera. So as we know more, we'll keep you posted, but that's how we see it right now.

One of the things also then, as I forgot is, we don't have the negative take-or-pace that we had last year in Brazil. So we don't expect them this year. So that will be a positive also.

Our next question comes from Heather Jones of Heather Jones Research.

I wanted to ask -- just wanted to, first of all, clarify that your guidance doesn't include any expected impact from tariffs. And then secondly, even if it doesn't include it, if you could just less show how that would look for you guys, how you to be thinking about the impact from your operations, particularly in North America?

Yes. Thank you, Heather, for the question. Yes, our guidance doesn't include any impact on tariffs as it's so difficult to predict at the moment. Tariffs imposed by the U.S. government tend to have a slightly positive benefit to us, whether it's lies in barriers or something. The issue is retaliatory measures, if you will, that others may apply into us.

As you saw, of course, the Mexico and Canada has been postponed for a month, the China retaliatory measures doesn't include agricultural products at this point in time. So it's difficult to know. I think in the short term, our teams are making sure that they are doing everything possible to avoid the short-term impact. I think medium term and long-term trade flows seem to stabilize but of course, we saw in 2018, how the corn imports from China was reduced by almost like 9 million tons from the U.S. whether that's going to be something that's going to happen again or not, we'll have to see.

Again, when you think about the power of ADM in terms of our origination in so many parts of the world and our destination marketing in so many parts of the world. It provides an optionality that few companies have in order to be able to capitalize on any environment. We don't know if net-net, it will be a positive or a negative, but we will go through as we went.

Our next question comes from Steven Haynes of Morgan Stanley.

I wanted to come back to Argentina and the recent export taxer vision across the soy crush complex. And if you could just briefly, I guess, talk about how you think that's going to impact your businesses? And then how many do you see that policy evolving after June because I think that's kind of when they had framed the current revision period for?

Yes. Thank you for the question, Steven. So let me -- this policy was implemented, as you said, effective until June 30, very difficult what's going to happen after that because it depends on more macroeconomics of Argentina. So it will depend on many, many factors. I would say, until then, we haven't seen a big impact yet mostly because they are still going through the harvest and to the plant in second because I'm a farmer in Argentina, we're all worried about the weather in Argentina and the crop in certain places doesn't look terrific.

We need rains that are expected to come, but those rains may just stabilize the yields, but not been able to turn around that. And then there are details about the implementation of this regulation that we need to be observing. Before all this, you get to -- you needed to bring the dollars into Argentina 30 days after your shipment. Right now, if you want to qualify for this reduction in exports, you need to commit that you're going to bring the dollars of 95% of all the amount within 15 days of issuing the license.

So before you have 30 days from shipment, now you have to bring the money 15 days after you get the export license. So that's a big financing chart change in the same that I don't know how it's going to impact. So we will have to see in April with the farmer seats on top of the harvest, and they have from April to May to June to be able to play this how much it's going to be. At this point in time, we haven't held much

Our next question comes from Pooran Sharma of Stephens.

I wanted to see if we could unpack 450 guidance a little bit. I know there's been -- the situation is fluid, Biden provided interim guidance, but I think there's a little bit left with final guidance. To my understanding, the biofuels industry with interim guidance is able to accrue tax credits but I think you need final guidance to have them paid out.

So we've seen some smaller operators already see shutter production -- we just weren't sure about the larger producers. So I wanted to kind of get your take on 45 guidance and then the state of the union on the biofuels industry.

Yes. Let's see if I can provide some clarity to that. First of all, this is preliminary guidance. And of course, it needs to be ratified after the comment period and then we need to see what the Trump administration will decide on this. So this still needs to be played out.

I would say with the removal of the blenders tax credit, margins have been significantly impacted. So you may see some small producers that in the absence of all these, when they are not integrated and are isolated plants, they have shut down. We were expecting to do that. Our integrated facilities, all our facilities are integrated have allowed us to continue to operate, although we see the impact in Q1 margins that we're going to have as we have Q4 margins.

So the industry definitely need to bring some margin back into it. More importantly, we need to bring clarity because lack of clarity have pulled people off the market. What we know is the administration of President Trump strongly support the farmers and having an output for the farmers' production.

And I think that in that sense, strong biofuel policy, a strong export policy, a strong biosolutions type of products are all going to be very supportive.

Appreciate the color.

Our next question comes from Manav Gupta of UBS.

I'm sorry, I dropped off briefly, so if somebody has already asked this, I apologize. But Monish, your key priorities when you took over your focus was one on operational rigor and second, ensuring there are no material weakness in financial reporting. And what's the progress been on those 2 fronts?

Yes. Thank you, Manav. I would say on both, and I'll start with the material weakness, as I said at the end of my prepared remarks, that is one item that we are very heavily focused on, which I am focused on. And the progress on that, and I'll start by just saying when we talked Q3 call and you had asked the question, I said the company had enhanced the design and controls and documentation of intersegment sales.

So we have continued to do that this quarter. We have continued to provide a lot of training to our personnel around the reporting and recognition of intersegment sales. We have enhanced and tested a lot of controls and we need to continue to make sure that is sustained for a period of time before we can lift the material weakness, and that's what the teams are focused on.

We also made an announcement where we've got [ Kerry Nicol, ] who's joining us as the Chief Accounting Officer who was from similar role in Cargill, and I'm excited to have her on board and my partner to help me continue this journey that we have started on remediating our material weakness. To answer your question on operating rigor, you can see that we've made progress in Juan's comments, you can hear that some of the items where we have done root cause and our manufacturing facilities have given yielded results.

In December, we saw good outputs in some of our plants in North America. We also saw progress in EMEA, in our Flavors business in Nutrition. And as a part of that whole thing, Manav, and as we look at the opportunities, Juan and I announced that we have a plan to get $500 million to $750 million of cost out over the next 3 to 5 years. it's going to come from multiple places.

Number 1 is driving efficiencies in our manufacturing facilities. Number 2 is going after costs with our third parties. And number 3 is controlling SG&A and some of the actions we're going to take there. Adding on to that on the other side is the simplification agenda. So as we continue to drive portfolio simplification, we see an opportunity to continue to drive margin enhancement in there, too, as some of these facilities, whether you talk about consolidation or targeted divestitures should allow us also benefit in there.

We're going to do all of this while at the same time, battling a lot more around the inflationary environment, whether it's the energy complex as well as labor inflation or general inflation that continues to stay. So focused on it. Juan said it, I've said it. It's a big self-help agenda. We know the environment that we are going into 2025.

And I think the team is quite confident that we can execute this cost-out plan that we've got over the next 3 to 5 years. Thank you so much for the update.

Our next question comes from Salvator Tiano from Bank of America.

I want to go back to Nutrition specifically for Q4. So your commentary was pretty positive in that Human Nutrition had higher volume and pricing versus last year. But if we adjust for last year's write-down, I think you would have made 39 million human [indiscernible] Whereas this year, without the insurance, you would have made only 15. So it looks like the performance or even with M&A was quite worse. So I cannot reconcile that two.

Can you provide a little bit more color on why margins were so lower and perhaps quantify the impact of this contract cancellation in Q4?

Yes. I think when you look at it, yes, we've made progress on the growth in Human Nutrition, but the biggest piece that still continue -- it continues to be a headwind is the Specialty Ingredients business. When you look at the continued inefficiencies from the downtime at Decatur East, the higher insurance premiums that we are seeing as well as the lower pricing for texturants and demand, all put together is where we landed up for the fourth quarter.

And going into 2025, we look at the same and say, when you look at Q1 and we say it's sequentially flat when you adjust for the insurance proceeds, the biggest driver there, again, on a year-over-year basis is the specialty ingredients. And so getting that plant back online in Q2 2025 and then doing all the sell-up actions that Ian and his team are doing in nutrition, will help us continue to grow Nutrition's P&L in 2025.

Just understand though here, the fire [indiscernible] happened, I think, August or September last year, meaning that you should have lumped -- at least in my understanding, you should have lapsed the inefficiencies and the problems already in Q4. So that shouldn't have been an issue versus Q4 of '24? Or it shouldn't be an issue in Q1, '25 versus what you posted this year?

Well, we had inventory going into Q4 of '23, and that allowed to reduce some of the impact that was there on a year-over-year basis. But also prices and end of expense come down yes.

Due to time, we'll take no further questions. So I'll hand back to Megan Britt for any further remarks.

Thank you so much for joining the call today. If you have additional questions, please feel free to reach out directly to me. Have a wonderful rest of your day.

Thank you all for joining today's call. You may now disconnect your lines.